​News Room

-A   +A

AAP Statement on FDA Action to Protect Effectiveness of Critical Antibiotics

By: Robert W. Block, MD, FAAP, president, American Academy of Pediatrics

"The American Academy of Pediatrics (AAP) applauds the Food and Drug Administration (FDA) on its request to drug companies today to help limit the use of medically important antibiotics in food-producing animals.

“This action is necessary to protect the usefulness of critical antibiotics and preserve the life-saving medicines pediatricians rely on to treat many serious childhood infections. We are pleased that the FDA has heeded the call of the public health community and taken this important step forward to protect children’s health.
“Pediatricians are already limited in the number and types of antibiotics that we can use to treat ill children, and when one type of antibiotic is found to be resistant to a strain of an infection, some of our sickest young patients are left without life-saving treatment options. The AAP commends the FDA for taking this crucial step in our children’s health, and calls on drug companies to cooperate with these voluntary guidelines.”
The American Academy of Pediatrics is an organization of 60,000 primary care pediatricians, pediatric medical subspecialists and pediatric surgical specialists dedicated to the health, safety and well-being of infants, children, adolescents and young adults. (www.aap.org)
            print           email           share